Table 1.
Baseline characteristics of women with and without TI
| Patient characteristics | Women with TI N =18 |
Women without TI N =31 |
P value |
|---|---|---|---|
| Age, y | 42 (11) | 38 (10) | 0.12 |
| Premenopausal, N (%) | 15 (83) | 26 (84) | 0.96 |
| Duration of HIV infection, y | 9.8 (4.8) | 8.2 (5.4) | 0.30 |
| Hormonal contraception, N (%) | 3 (17) | 2 (6) | 0.34 |
| Total T, nmol/L, mean Total T, nmol/L, median |
0.48 (0.27) 0.295 |
1.2 (0.79) 1.00 |
0.001 |
| cART use, N (%) | 16 (89) | 22 (72) | 0.18 |
| CD4 cell count, 10E6/L | 653 (376) | 572 (272) | 0.52 |
| Plasma viral load undetectable, N (%) | 16 (88) | 22 (71) | 0.15 |
| SHBG, nmol/L | 96.3 (75.2) | 75.9 (43.0) | 0.50 |
| Prolactin, μg/L | 12.0 (12.1) | 12.8 (9.5) | 0.51 |
cART = combination anti-retroviral therapy; T = testosterone; TI = testosterone insufficiency.